LL-III/2
General Information
DRACP ID DRACP00368
Peptide Name LL-III/2
Sequence NVWKKILGKIIKVVK
Sequence Length 15
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | Not available | MTT assay | 48 h | 1 |
SW480 | Colon adenocarcinoma | Carcinoma | IC50=11 µM | MTT assay | 48 h | 1 |
CCRF-CEM | Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia | Leukemia | IC50=7±2 µM | MTT assay | 48 h | 1 |
Hemolytic Activity Rat erythrocytes: IC50>200 μM
Normal (non-cancerous) Cytotoxicity HUVEC: not tested
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C86H152N22O17
Absent amino acids ACDEFHMPQRSTY
Common amino acids K
Mass 201620
Pl 11.4
Basic residues 5
Acidic residues 0
Hydrophobic residues 8
Net charge 5
Boman Index 68
Hydrophobicity 37.33
Aliphatic Index 162
Half Life
Mammalian: 1.4 hour
Yeast: 3 min
E.coli: >10 hour
Extinction Coefficient cystines 5500
Absorbance 280nm 392.86
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22100226
Title Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells
Doi 10.1016/j.peptides.2011.11.002
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available